Current evidence does not show that smoking cannabis increases the risk of esophageal cancer. The largest population-based study to examine this question found no elevated risk even among the heaviest users, and a systematic review in JAMA Network Open reached a similar conclusion. But “no evidence of increased risk” is not the same as “proven safe,” and the research here is surprisingly thin, relying on limited studies with small numbers of heavy cannabis-only smokers. The biology of cannabis smoke, the way THC interacts with the esophagus, and the difficulty of studying an illegal substance all complicate the picture in ways worth understanding.
What the Epidemiological Evidence Shows
The most direct evidence comes from a population-based case-control study that looked specifically at marijuana use and upper aerodigestive tract cancers, including esophageal cancer. Among people who had smoked the equivalent of 30 or more “joint-years” compared to non-users, the adjusted odds ratio for esophageal cancer was 0.53, meaning heavy cannabis users in the study were actually less likely to have esophageal cancer than non-users. That number came with wide confidence intervals, though, so the finding is consistent with anything from a modest protective effect to no meaningful association at all.1Cancer Epidemiology, Biomarkers & Prevention. Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study
A systematic review and meta-analysis published in JAMA Network Open assessed the broader landscape of marijuana and cancer. On esophageal cancer specifically, the review identified only one case-control study and concluded that marijuana use was not associated with increased risk. The authors flagged serious gaps: results were not broken out for marijuana-only smokers, the number of heavy users in the sample was low, and average marijuana exposure was not reported.2JAMA Network Open. Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis
So the short version is that nobody has found a positive link between cannabis smoking and esophageal cancer. But nobody has looked very hard, either. The entire body of direct epidemiological evidence on this specific cancer site amounts to one study and one review of that study. Contrast that with tobacco, where the link to esophageal cancer is backed by decades of research across hundreds of thousands of participants. Cannabis simply has not received that level of scrutiny for this particular disease.
Why Cannabis Smoke Should Theoretically Be Dangerous
If the epidemiology is reassuring, the toxicology is less so. Burning plant material produces harmful byproducts regardless of what plant it is, and cannabis smoke is no exception. A comprehensive comparison of mainstream marijuana and tobacco smoke found that both contain polycyclic aromatic hydrocarbons, which are well-established carcinogens. Tobacco smoke had greater contributions from aromatic and polycyclic aromatic compounds, while marijuana smoke contained more terpenes and sesquiterpenes.3Scientific Reports. Comprehensive characterization of mainstream marijuana and tobacco smoke A separate analysis found that mainstream marijuana smoke contained lower concentrations of selected PAHs than mainstream tobacco smoke, though the picture reversed for sidestream smoke (what drifts off the burning end), where marijuana actually produced higher PAH concentrations.4Chemical Research in Toxicology. A Comparison of Mainstream and Sidestream Marijuana and Tobacco Cigarette Smoke Produced under Two Machine Smoking Conditions
The practical takeaway is that cannabis smoke exposes the throat and esophagus to many of the same chemical classes that make tobacco smoke carcinogenic, just in a somewhat different mix. The concentration of any individual carcinogen may be lower, but the exposure is not zero. And the way people smoke cannabis, often inhaling more deeply and holding the smoke longer, could partly offset the lower concentrations by increasing contact time with tissue.
DNA Damage in Lab Studies
Laboratory studies have explored whether cannabis smoke can damage DNA at the molecular level, and the results are striking. When researchers exposed calf thymus DNA to the smoke from cannabis cigarettes, they found a dose-dependent increase in a specific type of DNA adduct (a chemical modification that can lead to mutations). Ten cannabis cigarettes produced roughly the same level of these adducts as ten tobacco cigarettes.5PubMed. Evaluation of the DNA damaging potential of cannabis cigarette smoke by the determination of acetaldehyde derived N2-ethyl-2′-deoxyguanosine adducts
In another set of experiments, marijuana smoke condensates proved to be more toxic to cells and more mutagenic (in the presence of metabolic activation) than comparable tobacco condensates.6PubMed. The genotoxicity of mainstream and sidestream marijuana and tobacco smoke condensates And when human lung cancer cell lines were exposed to marijuana smoke condensates, significant increases in DNA strand breaks and chromosomal changes were observed.7PubMed Central. The Role of p53 in Marijuana Smoke Condensates-induced Genotoxicity and Apoptosis
These findings present a genuine paradox. In the lab, cannabis smoke looks like it should cause cancer: it damages DNA, causes mutations, and kills cells. Yet population studies have not found the elevated cancer rates you would predict from those results. Several explanations have been proposed. THC and other cannabinoids have demonstrated anti-tumor properties in some experimental models, which could counteract some of the carcinogenic effects. People also smoke far less cannabis by volume than tobacco users smoke cigarettes, meaning lifetime cumulative exposure is typically much lower. And the research base in humans is simply too small to detect modest increases in risk, especially for a relatively uncommon cancer like esophageal cancer.
How THC Affects the Esophagus
Cannabis does not just pass through the esophagus as smoke. THC actively interacts with the esophageal tissue through cannabinoid receptors, and this produces some unexpected effects. In both animal models and healthy human volunteers, THC reduced transient lower esophageal sphincter relaxations, which are the primary mechanism behind acid reflux. THC also lowered resting pressure in the sphincter and reduced swallowing frequency.8PubMed Central. Effect of delta9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans
This is relevant because chronic acid reflux is the single biggest risk factor for esophageal adenocarcinoma, one of the two main types of esophageal cancer. By reducing these transient relaxations, THC could theoretically lower the amount of acid that splashes back into the esophagus. In the study of healthy volunteers, THC caused a non-significant reduction in acid reflux episodes during the first hour after a meal. Whether this translates into any long-term protection is unknown, but the mechanism at least partially explains why the epidemiological data has not found the risk increase you might expect from inhaling combustion byproducts.
That said, the relationship is not straightforward. Cannabis use is also associated with cannabinoid hyperemesis syndrome in some regular users, which involves repeated vomiting. Chronic vomiting can irritate the esophageal lining. And in at least one published case, a 41-year-old man who had smoked cannabis two to three times daily for 20 years was found on endoscopy to have extensive Barrett’s esophagus, a precancerous condition where the normal esophageal lining is replaced by tissue resembling the intestinal lining.9PubMed Central. Does Smoking Cannabis Increase the Risk of Barrett’s Esophagus? A small percentage of people with Barrett’s esophagus go on to develop adenocarcinoma.9PubMed Central. Does Smoking Cannabis Increase the Risk of Barrett’s Esophagus? One case report cannot establish causation, but it raises a question worth investigating in larger studies.
The Confounding Problem With Tobacco and Alcohol
Studying cannabis and esophageal cancer in isolation is difficult because cannabis users frequently also drink alcohol and smoke tobacco, both of which are established causes of esophageal cancer. The same population-based study that found no link between marijuana and esophageal cancer specifically tested for interactions between marijuana, tobacco, and alcohol. The researchers found no departure from what you would expect if the three substances acted independently, and no evidence of a positive association between marijuana and cancer even among people who were heavy tobacco or alcohol users.1Cancer Epidemiology, Biomarkers & Prevention. Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study The caveat, as the authors noted, is that all of these interaction results were very imprecise due to sample size.
This is one of the core methodological challenges in the field. An epidemiological review of marijuana use and cancer risk identified several recurring limitations across existing studies: possible underreporting in places where marijuana was illegal, small sample sizes, and too few heavy marijuana users in any given study to detect anything other than a very large effect.10PubMed. Epidemiologic review of marijuana use and cancer risk Esophageal cancer is rare enough that even large case-control studies struggle to accumulate enough cases among cannabis-only users to draw firm conclusions. As cannabis legalization spreads and self-reporting becomes less stigmatized, future studies should improve, but for now the data is genuinely limited.
Does Vaping Cannabis Change the Risk?
Many cannabis users have shifted from smoking to vaporizing, partly on the assumption that it is safer. The chemistry supports this to a degree. When researchers compared cannabis vaping aerosol to cannabis smoke in the lab, they found that vaping produced fewer toxicants overall. But “fewer” did not mean “none.” The vaping aerosol still contained compounds classified as carcinogens, teratogens, and respiratory toxicants.11PubMed. Cannabis vaping elicits transcriptomic and metabolomic changes involved in inflammatory, oxidative stress, and cancer pathways in human bronchial epithelial cells
The same study found that both cannabis smoke and cannabis vaping aerosol triggered gene expression changes in human bronchial cells related to inflammation, oxidative stress, and cancer-related pathways. The effects from vaping were less pronounced than from smoking, but they were still detectable. No long-term human studies have yet assessed whether vaping cannabis affects esophageal cancer risk, and given how recently vaping became widespread, those data are probably a decade or more away.
Edibles and other oral consumption methods sidestep the combustion question entirely. Without smoke or vapor passing through the esophagus, the direct chemical exposure to esophageal tissue is eliminated. THC still enters the bloodstream and can still interact with cannabinoid receptors in the esophagus, so the effects on sphincter relaxation and motility would persist. But the carcinogenic byproducts of combustion would not be a factor. For someone genuinely concerned about esophageal exposure specifically, switching away from inhaled cannabis is the most straightforward risk reduction.
Contaminants in Cannabis Products
A risk factor that gets far less attention than it deserves is what comes along with the cannabis rather than what the cannabis itself produces when burned. Common cannabis contaminants include microbes, heavy metals, and pesticides. Their direct human toxicity is poorly quantified, but potential harms include infection, carcinogenic effects, and reproductive harm.12PubMed Central. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects
This is particularly relevant in unregulated markets, where cannabis may be grown with pesticides not approved for inhalation or may harbor mold and fungal toxins. Some of these contaminants are themselves carcinogenic, and when burned and inhaled, they add an exposure layer that has nothing to do with the cannabis plant’s own chemistry. Regulated dispensaries in legal markets typically test for heavy metals, pesticides, and microbial contamination, though testing standards vary by state. Users in illegal or gray markets have essentially no way to know what they are inhaling beyond the plant itself.
Whether contaminants specifically contribute to esophageal cancer risk has not been studied directly. But the esophagus is the first mucosal surface that smoke contacts after the mouth and throat, so any carcinogenic contaminant in the smoke would have direct exposure to esophageal tissue. For people who smoke cannabis regularly, sourcing from tested, regulated products eliminates at least this one variable from an already uncertain risk equation.
Why This Question Is So Hard to Answer Definitively
Esophageal cancer is not common. In the United States, it accounts for roughly 1% of all new cancer diagnoses. The two main types, squamous cell carcinoma and adenocarcinoma, have different risk profiles: squamous cell is driven primarily by tobacco and alcohol, while adenocarcinoma is linked to chronic reflux and obesity. To detect whether cannabis contributes to either type, you need enormous study populations with detailed, honest self-reporting of cannabis use, and ideally populations where cannabis use and tobacco use do not overlap as heavily as they typically do.
Those studies do not yet exist. The research we have was conducted when cannabis was illegal throughout the United States, when self-reporting was unreliable, and when the sheer number of cannabis-only users willing to participate in studies was small. The population-based study that found no association had wide confidence intervals precisely because there were not enough heavy cannabis-using esophageal cancer cases to draw tight conclusions. A result consistent with both a 50% risk reduction and a 30% risk increase is not really telling you much beyond “we do not have the statistical power to answer this.”
Legalization is changing this landscape. As more people use cannabis openly, researchers can conduct larger prospective studies that follow users over time, with better exposure data and less underreporting bias. Until those studies mature, the honest answer remains that cannabis smoking has not been shown to cause esophageal cancer, but the evidence is not strong enough to rule out a modest risk. For the heaviest users, the lab evidence on DNA damage suggests caution is reasonable even without epidemiological proof of harm.